Last mentioned: 4h ago
Technical Working Groups
Expected formation of joint committees to align GMP and clinical trial standards.
Tariff Implementation
New 15% tariffs on Indian goods and other global imports take effect.
Public Announcement
Details of the bilateral agreement released to international media and regulatory stakeholders.
Negotiations Deferred
India and U.S. agree to reschedule the chief negotiator meeting.
New Delhi Declaration
88 nations sign a framework emphasizing Global South inclusivity and ethical impact.
MoU Exchange Initiated
Official diplomatic exchange of the regulatory cooperation document in the field of pharmaceuticals.
Tariff Announcement
Trump announces 10% global tariff, later increased to 15%.
SCOTUS Ruling
Supreme Court rules tariff authority belongs to the U.S. Congress.
Seoul AI Business Pledge
Focus on safety, innovation, and inclusivity in South Korea.
Bletchley Declaration
First major international agreement on AI safety signed in the UK.
India and the United States have indefinitely postponed high-level trade negotiations following a landmark U.S. Supreme Court ruling that shifts tariff-setting authority from the President to Congress. The delay comes as President Trump retaliated against the judicial check by imposing a 15% blanket tariff on all imports, including those from India.
India and Brazil have formalized a Memorandum of Understanding (MoU) to deepen bilateral cooperation in the regulation of pharmaceutical and medical products. This strategic alignment seeks to harmonize standards and streamline market access between two of the world's most significant emerging pharmaceutical hubs.
A coalition of 88 countries and international organizations has formally endorsed the New Delhi Declaration on AI at the India AI Impact Summit. The landmark agreement establishes a unified framework for ethical AI development, emphasizing inclusivity and the specific needs of the Global South.